# Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia

> **NCT02047305** · NA · COMPLETED · sponsor: **Covidien, GI Solutions** · enrollment: 96 (actual)

## Conditions studied

- ESOPHAGEAL SQUAMOUS CELL CARCINOMA

## Interventions

- **DEVICE:** Radiofrequency Ablation

## Key facts

- **NCT ID:** NCT02047305
- **Lead sponsor:** Covidien, GI Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2016-08
- **Final completion:** 2016-11
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2020-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02047305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02047305, "Radiofrequency Ablation for Patients With Esophageal Squamous Cell Neoplasia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02047305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*